# Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction（ELASTIC）

Study · id `cardio:ct-nct07563673` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07563673](<https://clinicaltrials.gov/study/NCT07563673>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07563673

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 210 participants.

## Technical summary

Registry record NCT07563673. Randomized; no masking; primary purpose treatment. Start 2026-05-01 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 210 participants (planned count; ClinicalTrials.gov record NCT07563673, source copy `cardio:ctgov-nct07563673-2026-05-08`, retrieved 2026-10-26)
- Planned start: 2026-05-01 (anticipated) (ClinicalTrials.gov record NCT07563673, source copy `cardio:ctgov-nct07563673-2026-05-08`, retrieved 2026-10-26)
- Primary completion: 2027-09-30 (anticipated) (ClinicalTrials.gov record NCT07563673, source copy `cardio:ctgov-nct07563673-2026-05-08`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07563673, source copy `cardio:ctgov-nct07563673-2026-05-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07563673, source copy `cardio:ctgov-nct07563673-2026-05-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07563673-2026-05-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction（ELASTIC）
- Acronym: ELASTIC
- Condition: Cerebral Infarction
- Condition: Thrombolysis
- Intervention (Drug): Aspirin (Early, 2h)
- Intervention (Drug): Aspirin (Standard, 24h)
- Lead sponsor: Beijing Chao Yang Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Beijing Chao Yang Hospital (`cardio:org-beijing-chao-yang-hospital`)

## Provenance

Content hash: 0df90fc4df4416606f918dfc1e26c60acbe708c452c3e40dd3043ea6063b5f11
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
